SCHEMBL6432429

SCHEMBL6432429

O=C(CC1SC(Nc2ccc(Oc3ccccc3)nc2)=NC1=O)NCc1c(F)cccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.39
FABP3 P05413 1/20 0.39
FABP4 P15090 1/20 0.39
ALDH1A1 P00352 1/20 0.38
P2RX7 Q99572 4/20 0.38
GAA P10253 2/20 0.38
LMNA P02545 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LTA4H P09960 1/20 0.35
GALR3 O60755 1/20 0.35
RAB9A P51151 1/20 0.35
ATM Q13315 1/20 0.35
KDM4E B2RXH2 1/20 0.34
NSD2 O96028 1/20 0.34
MAPT P10636 1/20 0.34
MAPK1 P28482 1/20 0.34
P2RX3 P56373 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6506396 0.81 P2RX7 (0.45) ALDH1A1P2RX7GAAL3MBTL1RAB9A
SCHEMBL6394322 0.78 KMT2A (0.42) ALDH1A1P2RX7L3MBTL1SMN1; SMN2ATM
SCHEMBL6498552 0.78 P2RX7 (0.46) ALDH1A1P2RX7GAAL3MBTL1RAB9A
SCHEMBL6468305 0.78 P2RX7 (0.48) ALDH1A1P2RX7GAAL3MBTL1RAB9A
Trifluoroacetic Acid SCHEMBL6389330 0.77 KMT2A (0.40) ALDH1A1P2RX7L3MBTL1SMN1; SMN2ATM
SCHEMBL6426489 0.74 P2RX7 (0.43) ALDH1A1P2RX7GAAL3MBTL1RAB9A
SCHEMBL6426339 0.74 LIPE (0.42) LTA4HRAB9AMAPTP2RX3
Hydrochloric Acid SCHEMBL6427199 0.70 P2RX7 (0.40) ALDH1A1P2RX7L3MBTL1ATMMAPT
SCHEMBL6388541 0.67 MAPT (0.46) ALDH1A1GAARAB9AKDM4ENSD2
SCHEMBL6427351 0.64 ALDH1A1 (0.51) ALDH1A1GAAL3MBTL1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050239853-A1 New compounds BIOVITRUM AB (SE) 2005-10-27 US claimed
WO-2005075471-A2 THIAZOL-COMPOUNDS AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS BIOVITRUM AB (SE) 2005-08-18 WO claimed
US-20050239853-A1 New compounds BIOVITRUM AB (SE) 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239853-A1 New compounds HSD11B1, CYP11B1, HSD3B1 DGAT1 584/4885FABP3 3293/4885FABP4 2544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.